The Osteoarthritis Research Society International's World Congress on Osteoarthritis concluded on April 21, with a clear focus on finding new ways to recognize the disease early and identify and slow progression.
Conferences page on Musculoskeletal Network features reports on the latest in osteoarthritis research, including:
Women with persistent antiphospholipid antibodies (aPLs) apparently have pregnancy outcomes similar to those of women under treatment for antiphospholipid syndrome (APS) and even comparable to unmatched controls. More »
New in the nonspecialty journals: A new option for patients with autoimmune disease and HCV infection. The value of combined therapy for osteoporosis. Prognosis predictors for chronic pain, a new opioid adverse effect, and more ... More »
Is it a form of lupus, myositis, or a drug reaction? Check your knowledge of skin eruptions and the associated rheumatologic conditions in this brief photo essay. More »
A 39-year-old woman, in her eighth week of pregnancy, experienced aching pain that worsened with activity. Weakness and fatigue set in three days later in her thigh and proximal arm muscle. Then a mildly pruritic rash developed across the forehead, nose, and forearms. More »
A small pilot trial from the Karolinska Institute finds positive results for rituximab in lupus nephritis patients for whom conventional treatments have failed. More »
New in the major nonspecialist journals: Bevra Hahn MD tells how she uses belimumab in lupus, a case report of an adverse effect of rituximab, a new proposal for identifying osteoporosis. More »
A small randomized trial from Italy found that while zoledronic acid (Reclast) slows bone loss in osteoporosis, it may also slow bone formation. Perhaps combination therapy is required. More »
Some patients with systemic lupus erythematosus or antiphospholipid syndrome may initially present with movement disorders, especially chorea. Physicians may not associate these symptoms with either disorder, thereby delaying diagnosis and effective treatment. More »
The latest results from two late-stage, multicenter clinical trials of belimumab (Benlysta) show that, when given alongside standard therapy for systemic lupus erythematosus, the drug improves health-related quality of life (HRQOL) and fatigue. More »
In lupus patients, urinary CD4 T cell counts correlate selectively and specifically with disease activity and renal involvement, well enough to be used to monitor the progress of treatment. More »
Osteoporosis is a common problem in thalassemics. As the most affected bone is spinal vertebrae, theoretically, it should have the greatest risk of fracture. However, vertebral fracture (VF) in thalassemics was rarely reported. Screening for asympt
Raloxifene and alendronate are anti-resorptive therapies approved for the prevention and treatment of postmenopausal osteoporosis. Raloxifene is also indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk of invasive breast cancer. A definitive study comparing the fracture effectiveness and rate of breast cancer for raloxifene and alendronate has not been published. The purpose of this retrospective cohort study was to eval
This is the main page for the National Institute of Arthritis and Musculoskeletal and Skin Diseases, one component of the National Institutes of Health, part of the U.S. Department of Health and Human Services.
Five Steps to Improving Patient Access Judy Capko, May 21, 2013 Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril Marion K. Jenkins, May 21, 2013 Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Three Areas to Reduce Costs at Your Medical Practice Greg Mertz, May 19, 2013 By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog Michael Woo-Ming, MD, May 18, 2013 Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
(AUDIO) Data from a long-term prospective study reveal that, for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your patient's next bone-density test.
(AUDIO) Harvard orthopedic surgeon Jeffrey Katz discusses one of his recent studies that looked at risk factors for revision surgery after total hip replacement.
![](http://www.musculoskeletalnetwork.com/image/image_gallery?img_id=2024804&t=1328052034554")
(AUDIO) Data from a long-term prospective study reveal that, for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your patient's next bone-density test.
(AUDIO) Harvard orthopedic surgeon Jeffrey Katz discusses one of his recent studies that looked at risk factors for revision surgery after total hip replacement.
